Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1223063-81-7 | MDL No. : | MFCD22576117 |
Formula : | C10H7FN2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | HAVPRINSIVTMIX-UHFFFAOYSA-N |
M.W : | 174.17 | Pubchem ID : | 58555936 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 47.43 |
TPSA : | 25.78 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.01 cm/s |
Log Po/w (iLOGP) : | 2.1 |
Log Po/w (XLOGP3) : | 1.91 |
Log Po/w (WLOGP) : | 2.7 |
Log Po/w (MLOGP) : | 1.33 |
Log Po/w (SILICOS-IT) : | 2.91 |
Consensus Log Po/w : | 2.19 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.74 |
Solubility : | 0.317 mg/ml ; 0.00182 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.07 |
Solubility : | 1.47 mg/ml ; 0.00842 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.45 |
Solubility : | 0.00625 mg/ml ; 0.0000359 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.06 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
27% | With dicyclohexyl-(2',6'-dimethoxybiphenyl-2-yl)-phosphane; palladium diacetate; sodium carbonate In ethanol at 85℃; for 16 h; Inert atmosphere | General procedure: A 10-mL Schlenk tube was charged with Pd(OAc)2 (1.7 mg, 0.0075 mmol, 3.0 mol percent), SPhos (6.2 mg, 0.015 mmol, 6.0 mol percent), Na2CO3 (53.0 mg, 0.50 mmol, 2.0 equiv), potassium 6-fluoropyridine-2-trifluoroborate (101.5 mg, 0.50 mmol, 2.0 equiv) and heteroaryl halides (0.25 mmol, 1.0 equiv), followed by the addition of ethanol (2.0 ml). The reaction was carried out at 85 °C for 16 h under the protection of nitrogen gas. Then, the reaction mixture was allowed to cool down to room temperature and the reaction solution was filtered through a thin pad of silica gel (eluting with ethyl acetate) and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel flash chromatography to produce the desired products (ethyl acetate/hexane=1:2-1:80). |
[ 1956437-56-1 ]
(S)-1-(6-Fluoropyridin-2-yl)ethanamine hydrochloride
Similarity: 0.77
[ 2061996-65-2 ]
(R)-1-(6-Fluoropyridin-2-yl)ethanamine dihydrochloride
Similarity: 0.77
[ 501009-05-8 ]
1-(6-Fluoropyridin-2-yl)ethanone
Similarity: 0.77
[ 1956437-56-1 ]
(S)-1-(6-Fluoropyridin-2-yl)ethanamine hydrochloride
Similarity: 0.77
[ 2061996-65-2 ]
(R)-1-(6-Fluoropyridin-2-yl)ethanamine dihydrochloride
Similarity: 0.77
[ 501009-05-8 ]
1-(6-Fluoropyridin-2-yl)ethanone
Similarity: 0.77
[ 884494-98-8 ]
(6-Fluoro-2-methylpyridin-3-yl)methanol
Similarity: 0.75